Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

NCT07160608 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Interventions

DRUG: Placebo
DRUG: Tarperprumig

Sponsor

Alexion Pharmaceuticals, Inc.